
Global Pathology Industry
Pathology involves the study of the damaging impact of disease on cells and tissues and the way in which the body seeks to protect and repair itself. Pathology can be divided into two main branches, namely clinical and anatomic.
1) Clinical pathology involves the analysis of bodily fluids to diagnose disease through laboratory testing. Pathologists study aspects of disease such as its cause, the way in which it develops, how disease changes cells and the clinical manifestations of this change. Chemical pathology involves biochemical testing of any bodily fluid, most commonly plasma or serum. This segment incorporates endocrinology, which is the study of endocrine gland cells and the tissues that produce them, immunology, and pharmacology, the study of drugs. In the branch of cytogenics pathologists study cells, particularly chromosomes. Cytogenetics has been used to study conditions such as Down syndrome. The Global Down Syndrome Foundation estimates Federal research funding was at $22 million in 2010.
Medical microbiology involves the analysis of microorganisms such as parasites, bacteria and viruses. This discipline provides information on how pathogens invade a host and the way in which the body protects itself. This allows medical professionals to determine how to best facilitate the immune system’s natural defense to heal infection. Advances in the field have led to vaccination against diseases such as tuberculosis. The discipline of medical microbiology includes the study of HIV. The Henry J. Kaiser Family Foundation reports 2011 federal spending on HIV/AIDS activities amounts to more than $20 billion in the US and almost $7 billion globally. With the World Health Organization estimating over 33 million people living with HIV in 2009 and close to 2 million deaths from AIDS, governments are likely to continue investing in pathology research into the disease.
2) The other main branch of pathology apart from clinical pathology is anatomic pathology, which involves the diagnosis of disease through laboratory analysis of the body. Anatomic pathology includes such fields of study as cytopathology, forensic pathology and surgical pathology. Forensic pathologists carry out autopsies on bodies to determine cause of death, disease or injury. It is a common practice in legal and criminal procedures and is often used to determine the circumstances of a person’s death.
Cytopathology involves the cellular study of disease and includes the screening process known as a pap smear, which is used to test for early signs of cervical cancer. Surgical pathology involves the analysis of biopsies and surgical resections. The former consists of removing a sample from a patient to make a diagnosis based on small structures to determine the presence of a tumor, and whether it is benign or malignant, in the treatment of cancer. Biopsy analysis is carried out to diagnose and treat other diseases such as those stemming from infection and inflammation. A surgical resection involves removing a diseased organ from a patient to avoid its continued damage to the body or its spreading to healthy surrounding organs.
Pathology Product Launches (2010)
| New Mechanism |
Other Brands |
| Actemra® |
rheumatoid arthritis |
Ablavar® |
blood-pool agent |
| Egrifta™ |
lipodystrophy |
Actoplus Met®XR |
type 2 diabetes |
| Ella® |
emergency contraceptive |
Beyaz-28™ |
oral contraceptive |
| Gilenya™ |
multiple sclerosis |
Cysview™ |
imaging agent for bladder cancer |
| Halaven™ |
breast cancer |
Duet DHA™Balanced |
prenatal vitamins |
| Prolia™ |
osteoporosis |
Dulera® |
asthma |
| Provenge® |
prostate cancer |
Ilotycin® |
antibiotic |
| Victoza® |
diabetes |
Iprivask™ |
thrombosis |
| Vpriv® |
Gaucher disease |
Jalyn™ |
BPH |
| Existing Mechanism |
Kombiglyze™XR |
type 2 diabetes |
| Xgeva™ |
bone metastases |
Lo Loestrin™FE |
oral contraceptive |
| Fanapt® |
schizophrenia |
Lumizyme® |
Pompe disease |
| Jevtana® |
prostate cancer |
Menveo® |
meningococcal bacteria |
| Livalo® |
cholesterol |
Mirapex®ER™ |
Parkinson's disease |
| Natazia™ |
oral contraceptive |
MuGard™ |
chemotherapy oral protectant |
| Pradaxa® |
thrombosis |
Prevnar 13® |
pneumonia |
| Xeomin® |
muscle activity |
Quadramet® |
bone metastases |
| Orphan |
Tekamlo™ |
hypertension |
| Ampyra® |
multiple sclerosis, walking ability |
Tozal® |
macular degeneration |
| Folotyn® |
T-cell lymphoma (CTCL) |
Tribenzor™ |
hypertension |
| Istodax® |
T-cell lymphoma (CTCL) |
Vimovo™ |
osteoarthritis pain |
| Kalbitor® |
angioedema |
Zyclara® |
skin irritation |
| Zortress® |
renal cell carcinoma |
Zyprexa®Relprevv™ |
schizophrenia |
|
Source: IMS Institute for Healthcare Informatics, The Use of Medicines in the United States: Review of 2010
Market Segments
Sub segments of clinical pathology include hematopathology, chemical pathology, cytogenics, and medical microbiology. Hematopathology deals with hematopoietic cells, which emanate from bone marrow and are involved in the production of blood cells such as platelets, red blood cells and white blood cells. When disease takes root within the hematopoietic network it can be detected and analyzed from a rise or fall in any of these cells. Hematopathologists study blood cells, bone marrow, lymph nodes, and biopsies to diagnose diseases such as lymphatic cancer and leukemia.
Pathology Industry Leaders
- Headquartered in California, Aperio provides digital pathology solutions for research, analysis, diagnostics and archival of pathology information. The company’s ScanScope is a system for the scanning of digitized glass slides to make high-resolution color digital slide images of glass slides. Aperio also offers Spectrum, a tailor-made management system for web-based digital pathology. Spectrum allows viewing of digital slides, conferencing, archiving, retrieval and analysis of image data. Spectrum also facilitates access by multiple users in multiple locations.
- Arizona-based Ventana Medical Systems Inc provides tissue-based diagnostic systems, in particular cancer testing from slides. In 2010 Ventana acquired Biolmagene to offer improved image analysis and data management. Ventana’s digital pathology solutions are used in clinical laboratories, hospitals, and pharmaceutical and biotech companies worldwide. Its products include iScan Coreo Au, a whole-slide scanner, and Virtuoso, a web-based software application used with iScan Coreo Au offering remote viewing, online conferencing, reporting and image analysis. The company equally sponsors PathXchange, a global online community for pathologists.
Digital Pathology
Substantial advances in pathology are being facilitated by the industry’s digitization. Pathologists are increasingly adopting digital pathology practices for speed, ease and cost reduction. Digital pathology represents a dynamic growth sector within the pathology industry. Through imaging pathologists can acquire and analyze pathology data from digitized glass slides. Slides are magnified 20, 40 or 100 times and digital equipment allows several pathologists to view and annotate the same slide from several sites simultaneously.
Leading Industry Associations
...More »
» Download Public Reports
About 8 600 reports
- Industry report
- May 2012
- 31 pages
... That nearly 100,000 people die annually from water pollution-related illnesses in china, and 75 percent of disease is linked to poor water quality. Recent scientific reports reveal that rates of liver ...
May 2012
... Of multiple sclerosis, tasq for prostate cancer and anyara for use in cancer targeted therapy, primarily of renal cell cancer. In addition, laquinimod is in phase ii development for crohn S and lupus. Further ...
May 2012
... Of infants born to hiv+ pregnant women receiving arv prophylaxis 2009 limited data available for number of infants tested limited data available for number of hiv infants enrolled in care and eligible ...
May 2012
... Experience and expertise in brain injury, spinal cord injury leading to tetraplegia and paraplegia, and other serious injury cases, including those leading to amputation. Warren collins is partner and head ...
May 2012
... Community health systems resource group director, ontario community outreach program for eating disorders associate professor, dalla lana school of public health, u of toronto core steering committee ...
May 2012
... Predicted tlc smaller in or than in on. We conclude that the major factor restricting tlc in some obese men was reduced thoracic expansion at full inflation. Magnetic resonance imaging; restricted total lung ...
May 2012
... Of obesity pulmonary disease abnormal function obstructive sleep apnea hypoventilation syndrome nonalcoholic fatty liver disease steatosis steatohepatitis cirrhosis gall bladder disease gynecologic ...
» Purchase Premium Reports
(From $ 44 - $ 9 120)
About 4 600 reports
- $ 11 400
- Industry report
- February 2012
- by Datamonitor
About This Report In 2009, HIV antiretroviral sales across the seven major industry s totalled USD 11.8 billion, growing at a CAGR of 10.8% between 2005 and 2009. While new cross-class fixed dose combinations ...
February 2012
$ 5 700
The large numbers of adults with dyslipidemia in the seven major industry s can be directly attributed to lifestyle choices, such as high caloric intake and limited physical activity. There is a clea ...
March 2012
$ 4 600
This report analyzes the worldwide markets for Endometriosis in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates ...
March 2012
$ 4 500
This report analyzes the worldwide markets for Breath Analyzers in Thousands of US Dollars by the following End-Use Segments: Regulatory Authorities, Employee Screening, and Healthcare. The report provides ...
May 2012
$ 5 003
This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...
May 2012
$ 5 003
This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...
May 2012
$ 5 003
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lymphoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts ...